Developing and validating a comprehensive polygenic risk score to enhance keratoconus risk prediction
Human Molecular Genetics · 2025
DOI: 10.1093/hmg/ddae157 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2025. Verfasst von Weixiong He und 9 weiteren Autor:innen. Beteiligte Einrichtung: QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, Queensland 4006, Australia. Hauptthemen laut MEDLINE: Keratoconus, Multifactorial Inheritance, Genetic Predisposition to Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Purpose
This study aimed to develop and validate a comprehensive polygenic risk score (PRS) for keratoconus, enhancing the predictive accuracy for identifying individuals at increased risk, which is crucial for preventing keratoconus-associated visual impairment such as post-Laser-assisted in situ keratomileusis (LASIK) ectasia.
Methods
We applied a multi-trait analysis approach (MTAG) to genome-wide association study data on keratoconus and quantitative keratoconus-related traits and used this to construct PRS models for keratoconus risk using several PRS methodologies. We evaluated the predictive performance of the PRSs in two biobanks: Estonian Biobank (EstBB; 375 keratoconus cases and 17 902 controls) and UK Biobank (UKB: 34 keratoconus cases and 1000 controls). Scores were compared using the area under the curve (AUC) and odds ratios (ORs) for various PRS models.
Results
The PRS models demonstrated significant predictive capabilities in EstBB, with the SBayesRC model achieving the highest OR of 2.28 per standard deviation increase in PRS, with a model containing age, sex and PRS showing good predictive accuracy (AUC = 0.72). In UKB, we found that adding the best-performing PRS to a model containing corneal measurements increased the AUC from 0.84 to 0.88 (P = 0.012 for difference), with an OR of 4.26 per standard deviation increase in the PRS. These models showed improved predictive capability compared to previous keratoconus PRS.
Conclusion
The PRS models enhanced prediction of keratoconus risk, even with corneal measurements, showing potential for clinical use to identify individuals at high risk of keratoconus, and potentially help reduce the risk of post-LASIK ectasia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, Queensland 4006, Australia.
- Faculty of Medicine, The University of Queensland, Brisbane, St Lucia, Queensland 4072, Australia.
- Department of Genetics, University Medical Centre Groningen Medical Faculty building (building 3211) 5th floor, Antonius Deusinglaan 1 9713 AV Groningen, The Netherlands.
- Estonian Genome Centre, Institute of Genomics, University of Tartu, Riia 23b, Tartu, Estonia.
- Eye Clinic, East Tallinn Central Hospital, Ravi street 18, 10138 Tallinn, Estonia.
- Department of Ophthalmology, Emory University, 201 Dowman Dr NE, Atlanta, GA 30322, United States.
ORCID-Profile: Weixiong He, Jue-Sheng Ong, Alex W Hewitt
Zitieren
APA
He, W., Võsa, U., Palumaa, T., Ong, J. S., Torres, S. D., Hewitt, A. W., Mackey, D. A., Gharahkhani, P., Esko, T., & MacGregor, S. (2025). Developing and validating a comprehensive polygenic risk score to enhance keratoconus risk prediction. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddae157
Vancouver
He W, Võsa U, Palumaa T, Ong JS, Torres SD, Hewitt AW, et al. Developing and validating a comprehensive polygenic risk score to enhance keratoconus risk prediction. Human Molecular Genetics. 2025. doi:10.1093/hmg/ddae157
BibTeX
@article{He2025,
author = {He, Weixiong and Võsa, Urmo and Palumaa, Teele and Ong, Jue-Sheng and Torres, Santiago Diaz and Hewitt, Alex W and Mackey, David A and Gharahkhani, Puya and Esko, Tõnu and MacGregor, Stuart},
title = {Developing and validating a comprehensive polygenic risk score to enhance keratoconus risk prediction},
journal = {Human Molecular Genetics},
year = {2025},
doi = {10.1093/hmg/ddae157}
}
EUVIMED